Evidence map›Paper›PMID 29285062›Full record

ArticleExperimental and therapeutic medicine2017

Effects of apigenin on the expression levels of B-cell lymphoma-2, Fas and Fas ligand in renal ischemia-reperfusion injury in rats.

Yang Liu, Xiuheng Liu, Lei Wang, Yang Du, Zhiyuan Chen, Hui Chen, Jia Guo, Xiaodong Weng, Xiao Wang, Ming Wang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Saudi journal of biological sciences · 2023
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yang LiuDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Xiuheng LiuDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Lei WangDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Yang DuDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Zhiyuan ChenDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Hui ChenDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Jia GuoDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Xiaodong WengDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Xiao WangDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Ming WangDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Zhishun WangDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Renmin Hospital of Wuhan University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the effect and possible mechanism of apigenin on renal ischemia-reperfusion (I/R) injury in rats, as well as in

Indexed as

apigeninB-cell lymphoma 2Fas/Fas ligandischemiareperfusion

Identifiers

PMID29285062
PMCPMC5740702
OpenAlexW2763800672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.